Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroTec is a German microbial biotechnology company focused on the development and industrial-scale production of microorganisms for the food and beverage, agriculture, and healthcare sectors. Its core offerings include starter cultures, protective cultures, probiotics, and contract fermentation services, with capabilities spanning process development, scale-up, freeze-drying, filling, and application support. In healthcare, the company appears to operate primarily as a B2B supplier and manufacturing partner rather than as a therapeutic drug developer with a disclosed clinical pipeline. MicroTec emphasizes customized strain and process development, industrial fermentation, and Europe-wide supply from its site in Steinfeld-Mühlen, Germany. The company also collaborates with external partners and universities on microbial solutions research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicroTec.